Skip to content
Dose Brief
Menu
The shortlist

Alternatives to Sesame Care

Sesame Care sits at No. 3 in our ranking with a Brief Score of 87. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs Sesame Care.

Our top alternative

No. 1 here

CoreAge Rx

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Coverage
US only; restrictions by state, confirmed at intake
Visit CoreAge Rx CoreAge Rx vs Sesame Care →

More providers worth weighing

No. 12 · Grade B+

Ro

87/100

Ro combines FDA-approved GLP-1 access and insurance support with a separate membership; compare the full bill, not the medication price alone.

Semaglutide

Wegovy pill from $149/mo + membership

$149 at 1.5 mg; $199 at 4 mg; $299 at 9/25 mg.

Membership: $39 first month, then $149/mo monthly; prepaid plans differ.

Full price details

Brand Wegovy pill from $149/mo for 1.5 mg, $199 at 4 mg, $299 at 9/25 mg, plus Ro membership: $39 first month then $149/mo on the monthly plan; prepaid care plans differ

Coverage
Confirm your state and selected medication during eligibility review
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 16 · Grade B+

No BS RX

87/100

No BS RX publishes standard, low-dose and brand prices separately, with bundled GLP-1 fees and an email cancellation process.

Semaglutide

$149/mo standard injection

Oral: $174/mo; separate low-dose programs: $115/mo.

Longer plans are listed in weeks; confirm payment and shipment timing.

Full price details

$149/month standard compounded injection; oral $174/month; separate low-dose programs $115/month

Coverage
Availability depends on program and state; complete state list not published
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 27 · Grade B

Hims & Hers

85/100

Hims now advertises branded GLP-1 options with a separate weight-loss membership. Compare the recurring membership charge as well as the medication price.

Semaglutide

Wegovy from $149/mo + membership

Pill from $149/mo; pen from $199/mo.

Membership: $39 first month, then $149/mo.

Full price details

Wegovy pill from $149/mo or pen from $199/mo, plus membership $39 first month then $149/mo

Coverage
Not available in all 50 states; confirm location and treatment eligibility
Price trend
new to the tracker, no prior reading
Visit Read the brief →

FDA warning letter, September 2025 — issued to Hims & Hers Health, Inc. dba Hims. See the FDA's warning letter database.

No. 47 · Grade B−

Mochi Health

81/100

Mochi separates insurance-based access from cash-pay membership. Medication and labs cost extra, so its $17 or $49 membership headlines are not GLP-1 totals.

Semaglutide

Wegovy from $149 + membership

Pill from $149; injection from $199.

Selected membership and applicable visit/lab costs extra.

Full price details

Wegovy pill from $149 or injection from $199, plus selected membership and applicable visit/lab costs

Coverage
Medication availability and pricing vary by state; confirm eligibility
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 148 · Grade C

MedLeanRx

71/100

MedLeanRx offers Texas patients starting-dose GLP-1 plans and separate brand-prescribing services, with dose changes and medication charges to confirm.

Semaglutide

$149/mo starting-dose offer

Compounded semaglutide vial; confirm the full prescribed dose and charge. Texas only.

Full price details

Compounded semaglutide offered; complete dose-specific quote unknown; $149/month starting-dose vial advertised; earlier listing: From $149/mo (starting dose, promotional rate, compounded)

Coverage
Texas only according to current practice and product pages
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 160 · Grade C

Wholesome Clinic

71/100

Wholesome Clinic is a Frisco, Texas integrative-psychiatry and wellness practice offering medical weight loss via telehealth across seven states.

Semaglutide

From $149/mo (starting dose, compounded)

Coverage
7 states
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 233 · Grade C

Allara Health

66/100

Allara combines medical and nutrition care; its $149 self-pay membership excludes prescriptions, and clinical access varies by state.

Semaglutide

Care and medication separate

Complete medical-and-nutrition care: $149/month self-pay. Semaglutide prescription costs are separate.

Laboratory costs and insurance cost-sharing may apply; branded oral and injectable choices need clinical review.

Full price details

Semaglutide medication quote unknown; branded options advertised; complete medical-and-nutrition care is $149/month self-pay, with prescriptions and possible laboratory costs separate

Coverage
Complete-care state list excludes Hawaii, Kansas, New Mexico, Rhode Island and South Carolina, where the FAQ lists nutrition-only membership; confirm individual clinical eligibility
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 286 · Grade C

Kin Meds

64/100

Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options.

Semaglutide

From $149/mo (brand Wegovy)

Coverage
Coverage not published
Price trend
new to the tracker, no prior reading
Visit Read the brief →

FDA warning letter, February 2026 — issued to Kin Meds. See the FDA's warning letter database.

Read our full Sesame Care brief →All comparisons →

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.